SCHEMBL18052000

SCHEMBL18052000

NC1CCC(Nc2nc(-c3c[nH]c4ncc(Cl)cc34)ncc2Cl)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 2/20 0.48
▸ DAPK3 O43293 2/20 0.48
▸ ROCK2 O75116 2/20 0.48
▸ PRKD3 O94806 2/20 0.48
▸ MAP4K4 O95819 2/20 0.48
▸ PAK4 O96013 2/20 0.48
▸ PIM1 P11309 2/20 0.48
▸ PRKACA P17612 2/20 0.48
▸ CDK2 P24941 2/20 0.48
▸ FLT3 P36888 2/20 0.48
▸ CSNK1A1 P48729 2/20 0.48
▸ CDK8 P49336 2/20 0.48
▸ CLK2 P49760 2/20 0.48
▸ GSK3B P49841 2/20 0.48
▸ PRKX P51817 2/20 0.48
▸ JAK3 P52333 2/20 0.48
▸ CDK5 Q00535 2/20 0.48
▸ MAP4K2 Q12851 2/20 0.48
▸ STK3 Q13188 2/20 0.48
▸ ROCK1 Q13464 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304242 0.90 CDC7 (0.47) CDC7DAPK3ROCK2PRKD3MAP4K4
SCHEMBL10304329 0.89 CDC7 (0.47) CDC7DAPK3PAK4PRKACACDK8
SCHEMBL18051995 0.87 FLT3 (0.46) CDC7DAPK3ROCK2PRKD3MAP4K4
SCHEMBL10304475 0.84 GSK3A (0.55) GSK3BGSK3A
SCHEMBL10303579 0.83 CDC7 (0.46) CDC7DAPK3ROCK2PRKD3MAP4K4
SCHEMBL10007974 0.83 CDC7 (0.46) CDC7DAPK3ROCK2PRKD3MAP4K4
SCHEMBL10007970 0.83 CDC7 (0.46) CDC7DAPK3ROCK2PRKD3MAP4K4
SCHEMBL18629031 0.83 — —
SCHEMBL10304124 0.80 GSK3A (0.54) GSK3BGSK3A
SCHEMBL10304356 0.80 GSK3A (0.54) GSK3BGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 — — EP disclosed
EP-2442809-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2016-08-31 — — EP disclosed
Send feedback